Be Our Guest!

View Calendar


Wise Elementary Fine Arts Magnet

2016-2017 Applications
 
  
Thank you for your interest in Wise Elementary Fine Arts Magnet.  We are excited at the possibility of serving your child.  We will begin accepting applications for the 2016-17 school year on Monday, March 14, 2016 at 7:00 A.M. here at Wise!  Please note, only completed applications will be accepted and time-stamped for placement consideration.   
 
Gracias por su interés en la escuela Wise de especialidades en Bellas Artes.  Estamos emocionados con la posibilidad de servir a su hijo.  Por favor llene la solicitud adjunta para el año escolar 2016-2017.  Empezaremos a aceptar solicitudes en Wise el lunes 14 de marzo a las 7:00 a.m.  Por favor tenga en cuenta que, solamente solicitudes completas serán aceptadas y serán selladas con la hora en que fueron recibidas lo cual se tomara en cuenta para colocación.
 
 
Transfer Application (For Students Outside of CHISD Only)



 


CHAPEL HILL ISD  2016-2017  Head Start Registration 

Elementary campuses will begin Head Start Registration, February 23, 2016 by appointment only.
Call to schedule an appointment, (903) 566-2271.
 

Child must be age 4 on or before Sept. 1, 2016

To determine if your child is eligible, please bring the required documents listed below.

· Two proofs of residency (must meet the criteria listed below)

· Student’s Birth Certificate

· Student’s Social Security Card

· Student’s Immunization Records

· Parent/Guardian Photo ID

· Proof of income (for Head Start: last year’s tax return, W-2/1040, Child Support, TANF/SSI, social security/disability, Employer Verification, other income)

· Proof of Medicaid, CHIP, or private health insurance, if you have it

 

Two acceptable proofs of residence within the district:

At least one MUST be:

· Primary Utility Bill which states the name of parent/legal guardian, residence address, and is dated within the last 30 days (Electricity, Gas, or Water)

· Lease agreement which states the name of residents including students, address of residence, dates of agreement, if utility payments are included or not included, and signed by Leaser and Lessee.

· Third Party Statement of Residence Form and two other acceptable proofs of residence attached

*  Signed by all parties and notarized or

*  Property/residence owner and parent/guardian must bring photo IDs to the campus registrar’s office where they must sign in person in the presence of the registrar

 

Acceptable as second proof:

· Other Bills which are services to the residence dated within the last 30 days (Cable, Dish, Direct TV, Landline Phone, and Sanitation)

· Letter/Contract of services hooked up to the residence (must be spending nights in the residence)

· Mortgage statement

· Tax appraisal statement from current year which states the name of parent/legal guardian, residence address and should show home on premises

Wise Elementary Fine Arts Magnet earned a TEA Distinction a POSTSECONDARY READINESS!

This means that Students at Wise Elementary Fine Arts Magnet are making HIGH scores on STAAR!  They are FUTURE READY!

 

Wise Elementary Fine Arts Magnet students MET STATE and FEDERAL STANDARDS on ALL FOUR INDEXES!

This means that students at Wise Elementary Fine Arts Magnet are making academic progress and closing the academic gaps!

Wise Elementary
Proudly Supports
     (Click Link Above)
 
                                                                                                                                 Watch Dogs

All Auvi-Q epinephrine injections recalled (Click Here for Full Article)

Posted: Oct 28, 2015 5:02 PM CDTUpdated: Oct 28, 2015 8:18 PM CDT
 Auvi-Q said anyone who has the drug should immediately get a new epinephrine pen by another company. (Source: PRNewsFoto/Sanofi)
Auvi-Q said anyone who has the drug should immediately get a new epinephrine pen by another company. (Source: PRNewsFoto/Sanofi)

(RNN) - Epinephrine injection pens under the brand name Auvi-Q, used to treat deadly allergic reactions, are being recalled over dosage concerns, manufacturer Sanofi announced in a statement.

CLOSE